These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 33206132)
1. Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis. Gregoire ARF; DeRuyter BK; Stratman EJ JAMA Dermatol; 2021 Feb; 157(2):198-201. PubMed ID: 33206132 [TBL] [Abstract][Full Text] [Related]
2. Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records. Zema CL; Valdecantos WC; Weiss J; Krebs B; Menter AM JAMA Dermatol; 2022 Oct; 158(10):1142-1148. PubMed ID: 35947363 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y; Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983 [TBL] [Abstract][Full Text] [Related]
4. Clinical Course and Characteristics of Generalized Pustular Psoriasis. Choon SE; Navarini AA; Pinter A Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):21-29. PubMed ID: 35061227 [TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Disease Burden of Patients with Moderate-to-Severe Generalized Pustular Psoriasis Flares in Taiwan. Lu CW; Tseng CY; Wang CW; Lin SH; Chen CB; Hui RC; Chi CC; Huang YH; Lee CH; Lin FJ; Chung WH Dermatol Ther (Heidelb); 2024 Aug; 14(8):2261-2275. PubMed ID: 39078583 [TBL] [Abstract][Full Text] [Related]
6. Clinical course and disease burden of patients with generalized pustular psoriasis in Portugal: a multicenter retrospective cohort study. Torres T; Antunes J; Brasileiro A; Alves J; Bernardo D; Ramos J; Sousa D; Castro C; Gusmão Palmeiro A; Aparício Martins A; Fazendeiro Matos J; Vieira Granja B; Ponte P; Marques Pinto G; Quirino P; Menezes Brandão F; Teixeira L; Magina S; Paiva Lopes MJ; Oliveira H; Varela P; Telles Sousa J; Filipe P; Tavares Bello R J Dermatolog Treat; 2024 Dec; 35(1):2345728. PubMed ID: 38684228 [TBL] [Abstract][Full Text] [Related]
7. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management]. Sukarovska BG; Lipozencić J; Vrzogić P Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis: A Randomized Clinical Trial. Atalay S; van den Reek JMPA; den Broeder AA; van Vugt LJ; Otero ME; Njoo MD; Mommers JM; Ossenkoppele PM; Koetsier MI; Berends MA; van de Kerkhof PCM; Groenewoud HMM; Kievit W; de Jong EMGJ JAMA Dermatol; 2020 Apr; 156(4):393-400. PubMed ID: 32049319 [TBL] [Abstract][Full Text] [Related]
9. Generalized pustular psoriasis: A nationwide population-based study using the National Health Data System in France. Viguier M; Bentayeb M; Azzi J; de Pouvourville G; Gloede T; Langellier B; Massol J; Medina P; Thoma C; Bachelez H J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):1131-1139. PubMed ID: 38404163 [TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis Flares. Choon SE; Lebwohl MG; Turki H; Zheng M; Burden AD; Li L; Quaresma M; Thoma C; Bachelez H Dermatology; 2023; 239(3):345-354. PubMed ID: 36796336 [TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open-label, phase 3 study (UNCOVER-J). Okubo Y; Mabuchi T; Iwatsuki K; Elmaraghy H; Torisu-Itakura H; Morisaki Y; Nakajo K J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):325-332. PubMed ID: 30317671 [TBL] [Abstract][Full Text] [Related]
12. Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020. Choon SE; Wright AK; Griffiths CEM; Wong KW; Tey KE; Lim YT; Chua KY; Ashcroft DM Br J Dermatol; 2023 Sep; 189(4):410-418. PubMed ID: 37162007 [TBL] [Abstract][Full Text] [Related]
13. Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review. Vincken NLA; Balak DMW; Knulst AC; Welsing PMJ; van Laar JM Rheumatology (Oxford); 2022 Nov; 61(11):4232-4244. PubMed ID: 35285486 [TBL] [Abstract][Full Text] [Related]
14. Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study. Kresch M; Weingarten M; Guenin S; Wei N; Elbogen E; Correa da Rosa J; Lebwohl M J Am Acad Dermatol; 2023 May; 88(5):1182-1183. PubMed ID: 36538947 [No Abstract] [Full Text] [Related]
15. Class I topical corticosteroid use by psoriasis patients in an academic practice. Pearce DJ; Spencer L; Hu J; Balkrishnan R; Fleischer AB; Feldman SR J Dermatolog Treat; 2004 Jul; 15(4):235-8. PubMed ID: 15764038 [TBL] [Abstract][Full Text] [Related]
16. [Severe psoriasis: 160 cases]. Jalal O; Houass S; Laissaoui K; Hocar O; Charioui S; Amal S Ann Dermatol Venereol; 2005 Feb; 132(2):126-8. PubMed ID: 15798561 [TBL] [Abstract][Full Text] [Related]
17. A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents. Bronckers IMGJ; Paller AS; West DP; Lara-Corrales I; Tollefson MM; Tom WL; Hogeling M; Belazarian L; Zachariae C; Mahé E; Siegfried E; Blume-Peytavi U; Szalai Z; Vleugels RA; Holland K; Murphy R; Puig L; Cordoro KM; Lambert J; Alexopoulos A; Mrowietz U; Kievit W; Seyger MMB; JAMA Dermatol; 2020 Apr; 156(4):384-392. PubMed ID: 32022846 [TBL] [Abstract][Full Text] [Related]
18. Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015. Polivka L; Oubaya N; Bachelez H; Paul C; Richard MA; Beylot-Barry M; Schmutz JL; Beneton N; Mahé E; Viguier M; Chosidow O; Canoui-Poitrine F; Sbidian E; J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1920-1929. PubMed ID: 29729123 [TBL] [Abstract][Full Text] [Related]
19. Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis. Kircik L; Lebwohl MG; Del Rosso JQ; Bagel J; Stein Gold L; Weiss JS J Drugs Dermatol; 2013 Dec; 12(12):1404-10. PubMed ID: 24301242 [TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory features in acute generalized pustular psoriasis: a retrospective study of 34 patients. Borges-Costa J; Silva R; Gonçalves L; Filipe P; Soares de Almeida L; Marques Gomes M Am J Clin Dermatol; 2011 Aug; 12(4):271-6. PubMed ID: 21495733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]